Delivery of 0.6 g/L and 0.9 g/L losartan in drinking water has been shown to reduce TGFβ signaling in the aorta in a mouse model of Marfan syndrome [23, 40] and in skeletal muscle of mice with induced injury, respectively [41]. This evidence concerns the gene TGFB1 and Marfan syndrome.